ABSCIENCES (EPA:AB) | Finanzwire

Basculer en Français

9473	Companies
185423	Keywords
117773	Articles
99292	Press releases

Home
Companies
ABSCIENCES

BRIEF

published on 06/09/2025 at 08:05, 5 months 26 days ago

EMA Approves Extended Shelf-Life for MASIVET® by AB Science

Veterinary Medicine AB Science EMA Approval MASIVET® Shelf-life Extension
PRESS RELEASE

published on 06/09/2025 at 08:00, 5 months 26 days ago

AB Science announces EMA approval of Masivet shelf-life extension to 4 years
AB Science receives EMA approval for 4-year shelf-life extension of MASIVET(R) veterinary medicine, providing enhanced flexibility for patients and caregivers

Veterinary Medicine AB Science EMA Approval Shelf-life Extension MASIVET
BRIEF

published on 05/23/2025 at 07:57, 6 months 13 days ago

AB Science strengthens its cash flow with a capital increase

Euronext Paris Investors Funding Capital Increase AB Science
PRESS RELEASE

published on 05/23/2025 at 07:52, 6 months 13 days ago

AB Science announces the settlement delivery of its latest capital increase for €1.8 million
AB Science settles €1.8 million capital increase to strengthen cash position and cover financing needs; focuses on innovative drug development for various diseases

Healthcare Industry Financial News Capital Increase Drug Development AB Science
BRIEF

published on 05/20/2025 at 07:54, 6 months 16 days ago

AB Science Completes EUR 1.8 Million Private Placement

Private Placement Euronext Paris Share Warrants AB Science AB8939 Development
PRESS RELEASE

published on 05/20/2025 at 07:49, 6 months 16 days ago

AB Science announces the successful completion of a EUR 1.8 million private placement
AB Science successfully completes EUR 1.8 million private placement for clinical development. New shares issued with warrants attached for financing ongoing activities

Private Placement Capital Increase Clinical Development Share Issuance AB Science
BRIEF

published on 05/19/2025 at 07:56, 6 months 17 days ago

AB Science obtains a patent in China for masitinib against COVID-19

COVID-19 Antiviral AB Science Masitinib Chinese Patent
PRESS RELEASE

published on 05/19/2025 at 07:51, 6 months 17 days ago

AB Science receives Chinese patent protecting masitinib in the treatment of Covid-19 until 2041, adding one more indication with long term intellectual property protection
AB Science receives Chinese patent protecting masitinib in the treatment of COVID-19 until 2041, providing long-term intellectual property protection. Collaboration with University of Chicago for COVID-19 research

Intellectual Property COVID-19 Treatment AB Science Masitinib Chinese Patent
BRIEF

published on 05/01/2025 at 10:11, 7 months 3 days ago

AB Science postpones the publication of its 2024 annual financial report

Euronext Paris Financial Report Publication Delayed AB Science Masitinib
PRESS RELEASE

published on 05/01/2025 at 10:06, 7 months 3 days ago

AB Science will publish its 2024 annual financial report on May 9, 2025
AB Science postpones the publication of its 2024 annual financial report to May 9, 2025, to allow auditors more time for audit work. The report will be released after trading hours

Financial Report Postponement Auditors AB Science 2024 Annual Report

Accesswire

Published on 12/05/2025 at 02:35, 7 hours 25 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 7 hours 30 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 9 hours ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 55 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 09:40, 20 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 30 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 55 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 1 hour ago

Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 09:00, 1 hour ago

SPECTRIS PLC - Removal

Les Echos

Published on 12/05/2025 at 08:45, 1 hour 15 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 16 hours ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 16 hours 15 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 16 hours 16 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 2 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE